CanFites

Liver Cancer Healthcare

Namodenoson Shows Protective Effects Beyond Liver Cancer in Can-Fite’s Pivotal Study

admin March 5, 2025 0

Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...

Read More

Why its kidney care dominance matters more now for investors

Why its kidney care dominance matters more now for investors

admin April 16, 2026 0

Transportation problems disrupt dialysis care for patients with kidney failure

Transportation problems disrupt dialysis care for patients with kidney failure

admin April 15, 2026 0

Kidney cancer guidelines published – Healthcare Today

Kidney cancer guidelines published – Healthcare Today

admin April 14, 2026 0

Improving early detection and treatment of liver cancer

Improving early detection and treatment of liver cancer

admin April 1, 2026 0

Bernice’s story highlights B.C.’s new liver transplant guidelines for Indigenous patients

Bernice’s story highlights B.C.’s new liver transplant guidelines for Indigenous patients

admin February 24, 2026 0